Skip to main content
Search
search
Link to Facebook page
Link to X
Link to YouTube channel
Link to flipboard
Link to RSS
Main navigation
Home
About
About ACSH
Financials
Our Team
Video
Donate
Publications
Media/Contact
Subscribe
Write For Us
Nash
email
facebook
twitter
linkedin
pocket
reddit
print
A New Drug Offers Hope For A Common, Life-Threatening Liver Disease
Addendum: The FDA granted resmetirom accelerated approval on March 14, 2024.
Read more
Beautiful Mind mathematician/economist and his wife died for want of a seatbelt. Don t let it happen to you
Ever since our late president Dr.
Read more
Subscribe to Nash
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
Human Brain Cells Taught to Play Doom. Seriously.
Healthcare without borders: How online consultations are bridging the accessibility gap
Podcast: From Boom to Bust and Back: The Real Story of Nuclear Power’s Renaissance
What If Sugar Were Regulated Like Opioids or Air Pollution?
Yet Another Netflix Improper-ganda Scary Science Show. This Time About Plastic
ACSH Podcasts
Podcast: From Boom to Bust and Back: The Real Story of Nuclear Power’s Renaissance
Podcast: Natural = Healthier? Busting Chemophobia Myths with Chemist Dr. Simon Maechling
Podcast: What MAHA Gets Wrong About America's 'Healthy' Past
Podcast: Some People Can't Enjoy Music. Science Has An Explanation
Podcast: What's Radiation Therapy for Cancer Really Like? An Expert (And Patient) Explains
More podcasts
Latest from Josh
Men: Wipe After You Pee (As Sung by the Rolling Stones)
How Do Hideous Mosquitoes Find You? Itching to Know? Read This.
The Evolution of Post-Fentanyl Drugs Mirrors That of Microbial Drug Resistance
Yet Another Netflix Improper-ganda Scary Science Show. This Time About Plastic
More articles
Latest from Chuck
Butterfat, Bots, and Bureaucrats: The Limits of Optimization
What If Sugar Were Regulated Like Opioids or Air Pollution?
Bring Out Your Dead: The Search For COVID’s Hidden Toll
Not So Fast : Why A Nuclear Power Cancer Risk Study May Overstate The Risk
More articles